
ORLANDO, FL – A recent study in Denmark using a cohort of recovered hepatitis C patients found that mRNA from Pfizer and Moderna circulates in the blood for 28 days after injection.
In the study, “SARS-CoV-2 Spike mRNA Vaccine Sequences Circulate in Blood up to 28 Days After COVID-19 Vaccination,” patients with chronic hepatitis C virus (HCV) infection received mRNA vaccinations according to the Danish roll-out vaccination plan. In 10 of 108 HCV patient samples, the researchers “surprisingly found fragments of COVID-19 vaccine mRNA up to 28 days postvaccination in blood from chronic HCV patients vaccinated with mRNA vaccines from both Pfizer-BioNTech and Moderna. Analysis of mRNA vaccine function has focused on the immune response and on protection of vaccinated individuals from SARS-CoV-2 induced severe COVID-19. “
